Webinars
Strategies to Advance iPSC Therapies to Clinic
Summary: In this presentation, our Expert discusses efforts underway at Catalent to accelerate the path to clinic for iPSC-based therapies.
View Now
Webinars
Reengineering CAR-T for Solid Tumors
Summary: Scientists are leading a well-funded drive to adapt technology for solid tumors while making the whole process much more economical for patients and payers.
View Now
Webinars
Manufacturing Considerations for Mesenchymal Cells and Broader Allogeneic Modalities
Summary: At Catalent, we implement innovative manufacturing and fill & finish methodologies to accelerate the path to commercial for MSCs and other allogeneic modalities.
View Now
Executive Summary
Repurposing Drugs for New Indications: Benefits and Challenges
Summary: In this webinar executive summary, industry experts share diverse insights about challenges and opportunities with repurposing drugs for new disease treatments.
View Now
Webinars
Then and Now – Delivering a Successful Therapeutic to Patients
Summary: Experts discuss the changing experience from the last quarter of a century in the pathway to patients, and how the latest advanced technologies translate into effective pre-clinical and clinical development and manufacturing.
View Now
Webinars
Moving to Commercial Readiness with a Dedicated Analytical Platform for T-cell Therapies
Summary: Experts discuss a breadth of analytical methodologies, fill & finish approaches and manufacturing designs to accelerate CAR-T therapies to commercial readiness phase in this on-demand webinar.
View Now
eBook
Novel Approaches to Improve Cell Therapy Manufacturing
Summary: Both cell therapy innovators and manufacturing organizations are employing novel technologies and methodologies to adapt to an accelerated and evolving clinical landscape
View Now
Webinars
Harnessing mRNA as a Readout to Develop Robust BioPotency Assays
Summary: Catalent has developed a relative potency bioassay using real-time quantitative reverse transcription (RT-qPCR) in a duplex format to assess relative transcription activity in cells treated with ligands or transgenic vectors.
View Now
Webinars
Repositioning Drugs for New Indications or Markets
Summary: In this interview, Catalent expert Judith Jones discusses the challenges associated with advancing a repositioned drug and how to overcome them to achieve strategic success.
View Now
Webinars
CAR-T Therapy: Working with a Manufacturing Partner
Summary: This roundtable is a must-watch for early and late-stage cell therapy innovator companies who are considering a manufacturing partnership.
View Now